letrozole has been researched along with Kallmann Syndrome in 1 studies
Kallmann Syndrome: A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked (GENETIC DISEASES, X-LINKED), an autosomal dominant, or an autosomal recessive trait.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hero, M | 1 |
| Tommiska, J | 1 |
| Vaaralahti, K | 1 |
| Laitinen, EM | 1 |
| Sipilä, I | 1 |
| Puhakka, L | 1 |
| Dunkel, L | 1 |
| Raivio, T | 1 |
1 trial available for letrozole and Kallmann Syndrome
| Article | Year |
|---|---|
Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
Topics: Adolescent; Anti-Mullerian Hormone; Aromatase Inhibitors; Biomarkers; Child; Cross-Sectional Studies | 2012 |